169 related articles for article (PubMed ID: 30444369)
1. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
[TBL] [Abstract][Full Text] [Related]
4. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
Marques AT; Fernandes PA; Ramos MJ
Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
[TBL] [Abstract][Full Text] [Related]
5. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
[TBL] [Abstract][Full Text] [Related]
6. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
Zakaria A; Hamdi N; Abdel-Kader RM
Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
[TBL] [Abstract][Full Text] [Related]
7. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
Benek O; Musílek K; Kuca K
Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
[TBL] [Abstract][Full Text] [Related]
8. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
[TBL] [Abstract][Full Text] [Related]
9. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.
Morsy A; Maddeboina K; Gao J; Wang H; Valdez J; Dow LF; Wang X; Trippier PC
ACS Chem Neurosci; 2022 Jul; 13(14):2176-2190. PubMed ID: 35802826
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
[TBL] [Abstract][Full Text] [Related]
11. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice.
Xiao X; Chen Q; Zhu X; Wang Y
Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial β-amyloid in Alzheimer's disease.
Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
[TBL] [Abstract][Full Text] [Related]
13. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
[TBL] [Abstract][Full Text] [Related]
15. Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?
Borger E; Aitken L; Du H; Zhang W; Gunn-Moore FJ; Yan SS
Curr Alzheimer Res; 2013 Jan; 10(1):21-9. PubMed ID: 22742981
[TBL] [Abstract][Full Text] [Related]
16. In silico-designed novel non-peptidic ABAD L
Viswanath ANI; Kim T; Jung SY; Lim SM; Pae AN
Chem Biol Drug Des; 2017 Dec; 90(6):1041-1055. PubMed ID: 28660722
[TBL] [Abstract][Full Text] [Related]
17. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD).
Powell AJ; Read JA; Banfield MJ; Gunn-Moore F; Yan SD; Lustbader J; Stern AR; Stern DM; Brady RL
J Mol Biol; 2000 Oct; 303(2):311-27. PubMed ID: 11023795
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
[TBL] [Abstract][Full Text] [Related]
19. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.
Yao J; Taylor M; Davey F; Ren Y; Aiton J; Coote P; Fang F; Chen JX; Yan SD; Gunn-Moore FJ
Mol Cell Neurosci; 2007 Jun; 35(2):377-82. PubMed ID: 17490890
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
Yan SD; Stern DM
Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
